Crestline Management, LP Syndax Pharmaceuticals Inc Transaction History

Crestline Management, LP

$1.88 Billion
Q3 2024

A detailed history of Crestline Management, LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Crestline Management, LP holds 428,538 shares of SNDX stock, worth $6.9 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

428,538

Previous 143,280 199.09%

Holding current value

$6.9 Million

Previous $2.94 Million 180.48%

% of portfolio

0.44%

Previous 0.23%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$17.93 - $24.81 $5.11 Million - $7.08 Million	285,258 Added 199.09%	428,538 $8.25 Million
Q2 2024 Aug 13, 2024	BUY	$18.82 - $23.79 $744,707 - $941,370	39,570 Added 38.15%	143,280 $2.94 Million
Q1 2024 May 14, 2024	BUY	$19.71 - $24.57 $60,332 - $75,208	3,061 Added 3.04%	103,710 $2.47 Million
Q4 2023 Feb 12, 2024	SELL	$11.39 - $21.67 $385,152 - $732,771	-33,815 Reduced 25.15%	100,649 $2.18 Million
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $319,440 - $478,940	22,000 Added 19.56%	134,464 $1.95 Million
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $333,884 - $384,959	17,255 Added 18.12%	112,464 $2.35 Million
Q1 2023 May 15, 2023	BUY	$20.66 - $28.98 $640,501 - $898,437	31,002 Added 48.28%	95,209 $2.01 Million
Q4 2022 Feb 13, 2023	BUY	$20.64 - $26.24 $13,539 - $17,213	656 Added 1.03%	64,207 $1.63 Million
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $55,530 - $74,370	3,000 Added 4.95%	63,551 $1.53 Million
Q2 2022 Aug 12, 2022	SELL	$13.64 - $19.48 $40,442 - $57,758	-2,965 Reduced 4.67%	60,551 $1.17 Million
Q1 2022 May 16, 2022	BUY	$14.84 - $22.15 $942,577 - $1.41 Million	63,516 New	63,516 $1.1 Million
Q3 2018 Nov 14, 2018	SELL	$6.33 - $8.08 $221,720 - $283,018	-35,027 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$6.93 - $14.63 $11,690 - $24,680	-1,687 Reduced 4.59%	35,027 $246,000
Q1 2018 May 15, 2018	SELL	$8.71 - $14.82 $404,361 - $688,018	-46,425 Reduced 55.84%	36,714 $522,000
Q4 2017 Feb 14, 2018	BUY	$7.8 - $12.94 $230,934 - $383,114	29,607 Added 55.31%	83,139 $728,000
Q3 2017 Nov 14, 2017	SELL	$10.9 - $12.73 $20,012 - $23,372	-1,836 Reduced 3.32%	53,532 $626,000
Q2 2017 Aug 14, 2017	BUY	N/A	55,368	55,368 $773,000

Others Institutions Holding SNDX

# of Institutions

227

Shares Held

88.3M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $911M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Crestline Management, LP with notifications on news.

Account

Crestline Management, LP Syndax Pharmaceuticals Inc Transaction History